NCT05460611Recruiting
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
A Pilot Study Evaluating the Safety and Efficacy of a 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Montefiore Medical Center
- Participants (registry)
- 10
- Start
- December 2023
- Primary completion
- July 2028 (planned)
- Study completion
- July 2028 (planned)
- Last registry update
- October 2026
- Countries
- United States
Conditions studied: Scarring Alopecia, Androgenetic Alopecia
Interventions: Sciton HALO 1470nm Non-ablative laser
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.